Therapeutic Group: Gastro Intestinal Disorders Presentation Diorin : Each tablet contains Diosmin (Micronized) BP 450 mg & Hesperidin BP 50 mg. Description The drug acts on the venous system by reducing the venous dilatation and stasis. It improves the micro-circulation by normalizing the capillary permeability and reinforcing the capillary resistance. Indications It is indicated in […]
Therapeutic Group: Gynaecological Presentation Dinosen : Each tablet contains Dienogest BP 2 mg. Description Dienogest is a nortestosterone derivative with antiandrogenic activity. Dienogest acts on endometriosis by reducing the endogenous production of oestradiol and thereby suppressing the trophic effects of oestradiol on both the eutopic and ectopic endometrium. Indications Dienogest is indicated for the treatment […]
Therapeutic Group: Anti Spasmodic Presentation Cyclopan tablet: Each tablet contains Dicycloverine Hydrochloride BP10 mg. Cyclopan syrup: Each 5 ml syrup contains Dicycloverine Hydrochloride BP 10 mg. Cyclopan injection: Each 2 ml injection contains Dicycloverine Hydrochloride BP 20 mg. Description Dicycloverine hydrochloride is an antispasmodic and anticholinergic (antimuscarinic) agent. Chemically, it is [Bicyclohexyl-]1-carboxylic acid, 2-(diethylammo) ethyl […]
Therapeutic Group: Nonsteroidal Anti-Inflammatory Presentation DicloGelTMGel: Each gram gel contains Diclofenac Diethylamine BP equivalent to Diclofenac Sodium 10 mg. Description Diclofenac is a potent nonsteroidal anti-inflammatory drug (NSAID) with clinically proven anti-inflammatory, analgesic and antipyretic properties. NSAIDs, including diclofenac, reduce pain principally by inhibiting formation of prostaglandins, leukotrienes and free oxygen radicals. All non-salicylate NSAIDs […]
Therapeutic Group: Analgesic, Anti Inflammatory Presentation Intafenac K : Each tablet contains Diclofenac Potassium BP 50 mg. Description Intafenac K is an immediate release tablet of Diclofenac Potassium that works by blocking the action of a substance in the body called cyclo-oxygenase. Cyclo-oxygenase is involved in the production of various chemicals in the body, some […]
Therapeutic Group: Respiratory Presentation Sudokof Antitussive Syrup: Each 5 ml syrup contains Dextromethorphan HBr BP 20 mg, Phenylephrine HCl BP 10 mg & Triprolidine HCl BP 2.5 mg . Description Sudocof syrup is a mixture of antitussive, decongestant and antihistamine agent. Dextromethorphan is used to suppress dry cough. Dextromethorphan is safe, effective and non-narcotic antitussive. […]
Therapeutic Group: Non-opioid antitussive Presentation Dilidex Syrup: Each 5 mL syrup contains Dextromethorphan Hydrobromide BP 6.5 mg, Diphenhydramine Hydrochloride BP 14 mg, and Levomenthol USP 2 mg. Description Dextromethorphan is a non-opioid antitussive drug. It exerts its antitussive activity by acting on the cough center in the medulla oblongata, raising the threshold for the cough […]
Therapeutic Group: Respiratory Presentation Tomephen Syrup: Each 5 ml of syrup contains Dextromethorphan Hydrobromide BP 10 mg. Description Dextromethorphan is the d-isomer of the codeine analog of levorphanol, but does not have any opiate-like effects. It is a non-narcotic antitussive. Its cough suppressant action is due to a central action on the cough center in […]
Therapeutic Group: Mild Anesthetic Presentation Detomax IV infusion: Each vial contains Dexmedetomidine Hydrochloride USP equivalent to Dexmedetomidine 200 mcg. Each normal saline bottle contains 48 ml 0.9% Sodium Chloride solution. Description Dexmeditomidine is a relatively selective alpha2-adrenergic agonist with sedative properties. Indications Dexmeditomidine is a relatively selective alpha2-adrenergic agonist indicated for: Sedation of initially intubated […]
Therapeutic Group: Proton Pump Inhibitor Presentation Delanix 30 capsule: Each capsule contains Dexlansoprazole INN 30 mg as enteric coated pellets. Delanix 60 capsule: Each capsule contains Dexlansoprazole INN 60 mg as enteric coated pellets. Description Delanix (Dexlansoprazole) delayed release capsule has been characterized as a gastric Proton Pump Inhibitor (PPI) that blocks the final step […]